title: Determination of excipient based solubility increases using the CheqSol method.
abstract: Aqueous solubility is an essential characteristic assessed during drug development to determine a compound's drug-likeness since solubility plays an important pharmaceutical role. However, nearly half of the drug candidates discovered today display poor water solubility; therefore methods have to be applied to increase solubility. Solubility determination using the CheqSol method is a novel rapid solubility screening technique for ionisable compounds. The aim of this study is to determine if the CheqSol method can be employed to determine solubility increases of four test drugs (ibuprofen, gliclazide, atenolol and propranolol) induced by non-ionising excipients such as hydroxypropyl-β-cyclodextrin and poloxamers 407 and 188. CheqSol assays were performed for the drugs alone or in combination with varying solubiliser concentrations. The measured intrinsic solubility of all four drugs increased with all the excipients tested in an excipient concentration dependent manner providing results consistent with previous literature. The results demonstrate that it may be possible to use this method to determine the solubility increases induced by non-ionic solubilising excipients with results that are comparable to standard equilibrium based solubility techniques. Since the technique is automated and requires only small drug quantities it may serve as a useful solubility or formulation screening tool providing more detailed physicochemical information than multiwell plate or similar visual systems.
authors: Strathclyde Institute of Pharmacy and Biomedical Sciences,University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, United Kingdom. Electronic address: kelly.etherson@strath.ac.uk.
authors: Kelly
authors: K
authors: Etherson
authors: Strathclyde Institute of Pharmacy and Biomedical Sciences,University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, United Kingdom.
authors: Gavin
authors: G
authors: Halbert
authors: Strathclyde Institute of Pharmacy and Biomedical Sciences,University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, United Kingdom.
authors: Moira
authors: M
authors: Elliott
mesh_terms: D000073738:2-Hydroxypropyl-beta-cyclodextrin; D001262:Atenolol / Q000737:chemistry; D057205:Automation, Laboratory; D002626:Chemistry, Pharmaceutical; D005079:Excipients / Q000737:chemistry*; D005907:Gliclazide / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D007052:Ibuprofen / Q000737:chemistry; D007700:Kinetics; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D020442:Poloxamer / Q000737:chemistry; D011199:Potentiometry; D011433:Propranolol / Q000737:chemistry; D012995:Solubility; D013678:Technology, Pharmaceutical / Q000379:methods*; D047392:beta-Cyclodextrins / Q000737:chemistry
chemical_list: D005079:Excipients; D004364:Pharmaceutical Preparations; D047392:beta-Cyclodextrins; D020442:Poloxamer; D000073738:2-Hydroxypropyl-beta-cyclodextrin; D001262:Atenolol; D011433:Propranolol; D005907:Gliclazide; D007052:Ibuprofen
keywords: CheqSol; Hydroxypropyl-β-cyclodextrin; Monoprotic acids; Monoprotic bases; Poloxamers; Solubility